BTDG .0004 VERY IMPORTANT POST: I have not posted this on

New Post Public Reply Private Reply Replies (0) Message Board
stockfalcon
BTDG .0004 VERY IMPORTANT POST: I have not posted this on IHUB yet but will shortly. I did post we spoke but not the whole conversation. Let me be upfront, he did not tell me anything that was a material event or not in recent or past filings. He said there is a lot going on that shareholders will be updated shortly. The company was recently brought current on otcmarkets.com. An 8k came out first week of December showing the DirectTV judgement has been paid and settled. This 8k comes with exhibits/letters from the US DEPT of JUSTICE to show proof. Paul said this was very important for the company to move forward because it was like a 1,000 pound gorilla...He was trying to get this done for a long time to move on and was finally able to do it. Now they have a clean shell and can load additional assets in it or do a reverse merger with another company. He said the debt for the company is very low now and has about $300k in assets. Insides own about 60% of the OS and the float is about 1.3B and that it has not changed in a long time. If you check the quarterly issued in Sept. 2016, this checks out. I called the TA as well, and they said to nothing here has changed with the share structure. SEE BELOW:

Finally he said expect more 8k's and News to come out very shortly on whats going on behind the scenes. He said that he has numerous relative and friends involved in the stock owning shares and has promised to get the price back up...way up. That is his mission right now and he said things are moving along extremely well. I personally believe this is a reverse merger type deal with the clean shell now thats going on. There were subtle things conversed to make me say this and feel this way. Thinks about it: Why would he pay $157,000 plus legal expenses out of his own pocket to get this done and move forward. Also, to bring the company in good standing on otcmarkets.com and ACTIVE costs money. This was all done recently in conjunction with settling this judgement.


BTDG 11777J304 (176) $0.01
NUMBER OF SHARES OR TOTAL AMOUNT OF SECURITIES OUTSTANDING FOR EACH CLASS OF SECURTIES AUTHORIZED
As of September 30, 2016, the Issuer has 4,219,867,388 shares of Common Stock issued and outstanding. As of September 30, 2016, the Issuer has 4,219,867.388 shares of Common Stock issued and outstanding.

Period End Date
September 30, 2016 5,000,000.000 June 30, 2016 5,000,000.000 March 31, 2016 5,000,000.000 December 31, 2015 5,000,000.000 March 31, 2015
March 31, 2014
March 31, 2013
OUTSTANDING SHARES 4,219,867.388 4,219,867.388 4,219,867.388
4,219,867.388 4,219,867,388 4,219,867,388
4,219,867,388 4,219,867,388
FLOAT 1,304,945,242 1,304,945.242 1,304,945.242
March 31, 2012
5,000,000,000 A/S

http://www.otcmarkets.com/financialReportView...;id=163895

http://www.otcmarkets.com/financialReportView...;id=162791
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 10

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 11

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 9

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 15

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercury Capital Secures $4.35M Loan for Retail Hub

Updated Category News Views 21

Mercury Capital Partners Banks on Retail Development They say the beauty's in the numbers, but the magic happens when you make those numbers work for you. Mercury Capital Partners (MCP) is wrangling dollars like no one's business, pushing a $4.35 million construction loan into the Fort Myers scene like it's a walk in the park. We're looking at Estero Oaks, a...

Continue Reading
Amazon Analysts Update Forecasts for Upcoming Earnings Report

Updated Category News Views 130

Amazon's Upcoming Earnings Call Amazon.com, Inc. (NASDAQ: AMZN) is set to unveil its earnings results for the second quarter. This announcement will provide valuable insights into the company's financial health and operational performance. Market expectations are leaning toward a positive outlook, as analysts predict robust earnings and revenue growth. Predicted Earnings...

Continue Reading
Understanding the Recent Surge in ServiceNow Options Activity

Updated Category News Views 82

Understanding the Recent Surge in ServiceNow Options Activity Recently, a notable shift occurred in the options market surrounding ServiceNow (NYSE: NOW), drawing attention from both institutional and retail investors. With deep pockets behind these moves, it's crucial to analyze what it could mean for the future of the stock. It’s always intriguing when a significant...

Continue Reading
Join the Exciting Bybit Boost Battle for Weekly USDT Prizes!

Updated Category News Views 176

Join the Exciting Bybit Boost Battle for Weekly USDT Prizes! Bybit, recognized as the second-largest cryptocurrency exchange globally by trading volume, has initiated a vibrant competition called the Boost Battle. This thrilling event allows traders to participate weekly, showcasing their skills and strategies. The grand prize rolls out weekly, presenting winners with the...

Continue Reading
Desert Control's Q2 Progress: Innovations and Financial Insights

Updated Category News Views 190

Desert Control's Q2 2025 Report Summary Desert Control AS (DSRT) has made commendable strides in the second quarter of 2025, revealing significant operational achievements and promising financial results. This report encapsulates the journey and progress of the company, focusing on their innovative solutions that enhance soil health and water conservation. Operational...

Continue Reading